Main Article Content
Introduction: Diabetes mellitus results in the state of imbalance in oestrogen and testosterone; more so, females exhibit increased circulating testosterone along with decreased in oestrogen level in diabetes mellitus. It is suggested that, sex hormones are important regulators of glucose and lipid metabolism. Tetrahydrobiopterin bioavailability which is an important modulator of these metabolites may be involved in sex hormones metabolism. In current work we investigated the effect of tetrahydrobiopterin administration on sex-hormones levels in diabetes mellitus.
Materials and Methods: Thirty (30) albino Westar rats (15 males and 15 females) weighing 100-120 g was divided into three groups: Controls (5 males and 5 female), diabetics (5 males and 5 females) and diabetics supplemented with tetrahydrobiopterin (5 males and 5 female). Diabetic groups received a single intra venous injection of Streptozotocin (STZ, 60 mg/ kg) while the control group were injected with a similar volume of citrate buffer. Tetrahydrobiopterin 20 mg/kgbw/day was supplemented for two weeks. Fasting Plasma Glucose, oestrogen and testosterone were estimated in all the groups.
Results: The mean Fasting plasma glucose concentration was significantly lower (p<0.05) in controls males (5.24±0.15 mmol/l) and females (5.43±0.15 mmol/l) and treated males (7.66±0.22 mmol/l) and females (7.20±0.36 mmol/l) compared to untreated males (15.68±2.84 mmol/l) and females (19.40±4.13 mmol/l). The mean plasma oestrogen concentration in control males (12.75±4.52 g/ml) and females (111.72±6.42 pg/ml) and treated males (15.16±2.08 pg/ml) and females (103.74±2.41 pg/ml) were significantly higher (p<0.05) than untreated males (5.33±1.36 g/ml) and females (66.84±20.88 pg/ml). The mean plasma testosterone concentration for females in control and treated groups were significantly lower (p<0.05) than untreated while there is no significant difference in mean values for males across the groups (p>0.05).
Conclusion: Diabetes resulted in oestrogen and testosterone imbalance and tetrahydrobiopterin administration restores level to near normal.
Scarabin-Carre V, Canonico M, Brailly-Tabard S, Trabado S, Ducimetiere P, Giroud M, Ryan J, Helmer C, Plu-Bureau G and Guiochon-Mantel A. High level of plasma estradiol as a new predictor of ischemic arterial disease in older postmenopausal women: The three-city cohort study. Journal of the American Heart Association. 2012;1(3): e001388.
Ane CD, Tom IN, Lars V, KristianM, Rure W. Diabetes mellitus and risk of fatal ischaemic heart disease by gender: 18 years follow-up of 74914 in the HUNT 1 study: European Heart Journal. 2007;28: 2924-2929.
Melissa ER, Kimberley MM, James RB, Chanchal C, John PH, Lea MDD. American Journal of Physiology - Heart and Circulatory Physiology. 2013;305: 779-792.
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, deSimone G, Ford ES. Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation. 2011; 123(4):e18-e209.
Traish AM, Saad F, Feeley RJ, Guay A. The dark side of testosterone deficiency: III. Cardiovascular disease. Journal of Andrology. 2009;30(5):477-494.
Cignarella A, Bolego C, Pinna C, Zanardo R, Eberini I, Puglisi L. The influence of sex hormones on vascular responses in the aorta of streptozotocin-diabetic male rats. Naunyn Schmiedebergs Arch Pharmacol. 2000;361:514–520.
Ulrich F, William CS. Nitric oxide synthase regulation and function. European Heart Journal. 2012;33:829-837.
Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003;111:1201–1209.
AHA. American Heart Association. Endothelial nitric oxide synthase in vascular disease, from marvel to menace. 2014;ISSN:1524-4539.
Akbarzadeh A, Norouzian D, Mehrabi MR, JamshidiSH, Farhangi A, Verdi AA. Induction of diabetes by Streptozotocin in rats. Ind J Clinical Boichem. 2007;22(2): 60-64.
Kase H, Hashikabe Y, Nakanishi N, Hattori Y. Supplementation with tetrahydro-biopterin prevents the cardiovascular effects of angiotensin II-induced oxidative and nitrosative stress. J Hypertens. 2005; 23(13):1375-82.
Dallatu MK, Anaja PO, Bilbis LS, Mojiminiyi FB. Antioxidant micronutrient potentials in strengthening the antioxidant defence in alloxan-induced diabetic rats. Nigerian Journal of Pharmaceutical Sciences. 2009;8(1):89-94.
Trinder P. Annals of biochemistry, 6:24. In, Cheesbrough, M. Medical laboratory manual for tropical countries, ELBS, Cambridge. 1992;1(2nd ed.):527-545.
Tiez Textbook of clinical chemistry, 2nd ed. Philadelphia: W.B saunders; 1994.
Abudukadier A, Yoshihito F, Akio O, Akiko O, Toru F, Yuichi SO, et al. Tetrahydrobiopterin has a glucose-lowering effect by suppressing hepatic gluconeogenesis in an endothelial nitric oxide synthase–Dependent Manner in Diabetic Mice. Diabetes. 2013;62:3034.
Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006; 295:1288–1299.
Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, Pettinger M, Heckbert SR, Greep N, Crawford S. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med. 2006; 166(3):357-365.
Duckles SP, Miller VM. Hormonal modulation of endothelial NO production. Pflugers Arch. 2010;459:841–851.
Dallatu MK, Bunza JM. Uncoupling of nitric oxide synthase predisposes diabetic rats to cardiovascular risk events. A paper presented at the Sub-Saharan /Omiccs international preconference workshop on haematology and blood disorders, Abuja, 10th to 13th May, 2016 at Nubunga Hall, Vine Hotel, Plot 1104, Mohammed N. Umar Lane Along Living Faith Church Road, Durumi Area, Abuja, Nigeria; 2016.